Xvivo Perfusion AB
STO:XVIVO

Watchlist Manager
Xvivo Perfusion AB Logo
Xvivo Perfusion AB
STO:XVIVO
Watchlist
Price: 502 SEK -2.14% Market Closed
Market Cap: 15.8B SEK
Have any thoughts about
Xvivo Perfusion AB?
Write Note

Wall Street
Price Targets

XVIVO Price Targets Summary
Xvivo Perfusion AB

Wall Street analysts forecast XVIVO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for XVIVO is 544.48 SEK with a low forecast of 484.8 SEK and a high forecast of 613.2 SEK.

Lowest
Price Target
484.8 SEK
3% Downside
Average
Price Target
544.48 SEK
8% Upside
Highest
Price Target
613.2 SEK
22% Upside
Xvivo Perfusion AB Competitors:
Price Targets
TOPGLOV
Top Glove Corporation Bhd
18% Downside
NAN
Nanosonics Ltd
10% Upside
137310
SD Biosensor Inc
10% Downside
ESTA
Establishment Labs Holdings Inc
32% Upside
HARTA
Hartalega Holdings Bhd
10% Downside
300981
Zhonghong Pulin Medical Products Co Ltd
4% Downside
300832
Shenzhen New Industries Biomedical Engineering Co Ltd
33% Upside

Revenue
Forecast

Revenue Estimate
Xvivo Perfusion AB

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's revenue is 22%. The projected CAGR for the next 4 years is 41%.

22%
Past Growth
41%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Xvivo Perfusion AB

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's operating income is -4%. The projected CAGR for the next 3 years is 331%.

-4%
Past Growth
331%
Estimated Growth
Estimates Accuracy
-32%
Average Miss

Net Income
Forecast

Net Income Estimate
Xvivo Perfusion AB

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's net income is 43%. The projected CAGR for the next 3 years is 52%.

43%
Past Growth
52%
Estimated Growth
Estimates Accuracy
-56%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is XVIVO's stock price target?
Price Target
544.48 SEK

According to Wall Street analysts, the average 1-year price target for XVIVO is 544.48 SEK with a low forecast of 484.8 SEK and a high forecast of 613.2 SEK.

What is Xvivo Perfusion AB's Revenue forecast?
Projected CAGR
41%

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's revenue is 22%. The projected CAGR for the next 4 years is 41%.

What is Xvivo Perfusion AB's Operating Income forecast?
Projected CAGR
331%

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's operating income is -4%. The projected CAGR for the next 3 years is 331%.

What is Xvivo Perfusion AB's Net Income forecast?
Projected CAGR
52%

For the last 8 years the compound annual growth rate for Xvivo Perfusion AB's net income is 43%. The projected CAGR for the next 3 years is 52%.

Back to Top